Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hantzsch Reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101759631A details a chromatography-free synthesis of Clevidipine Butyrate achieving >99.5% purity, offering significant cost reduction and scalability for API manufacturing.
Patent CN102070611A reveals a high-yield, two-step Hantzsch route for amlodipine intermediates, offering significant cost reduction and scalable manufacturing for global API producers.